Acute and emergency care for thyrotoxicosis and thyroid storm
- 12 May 2015
- journal article
- review article
- Published by Wiley in Acute Medicine & Surgery
- Vol. 2 (3) , 147-157
Abstract
Thyroid hormones affect all organ systems and, in excess, can cause increased metabolic rate, heart rate, ventricle contractility, and gastrointestinal motility as well as muscle and central nervous system excitability. Thyroid storm is the extreme manifestation of thyrotoxicosis with an estimated incidence of 0.20 per 100,000 per year among hospitalized patients in Japan. The mortality of thyroid storm without treatment ranges from 80% to 100%; but with treatment, the mortality rate is between 10% and 50%. The diagnostic strategy for thyroid storm may take into consideration Burch–Wartofsky scoring or Akamizu's diagnostic criteria. Multiple treatment aims need to be addressed in managing thyroid storm effectively. This paper puts together all aspects to be considered for the management of hyperthyroidism and thyroid storm during the acute and emergency phase as well as consideration of special populations.Keywords
This publication has 27 references indexed in Scilit:
- Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide SurveysThyroid®, 2012
- Intravenous Methimazole in the Treatment of Refractory HyperthyroidismThyroid®, 2006
- Antithyroid DrugsNew England Journal of Medicine, 2005
- Hyperthyroid heart diseaseClinical Cardiology, 2000
- Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmiasClinical Cardiology, 1996
- Use of esmolol in managing a thyrotoxic patient needing emergency surgeryThe American Journal of Medicine, 1990
- Thyrotoxicosis, atrial fibrillation, and embolism, revisitedAmerican Heart Journal, 1989
- Stroke in thyrotoxicosis with atrial fibrillation.Stroke, 1988
- Hyperthyroidism and Mitral-Valve ProlapseNew England Journal of Medicine, 1981
- Influence of Thyroid Dysfunction on Drug PharmacokineticsClinical Pharmacokinetics, 1981